Gambia vs Mexico: Cause of death, by non-communicable diseases, ages 60+, female
Gambia
65.0%
in 2021
Mexico
63.9%
in 2021
Gambia rank
149th
Mexico rank
152nd
Cause of death, by non-communicable diseases, ages 60+, female over time
- Gambia
- Mexico
How they compare
Gambia currently reports 65.0% against 63.9% in Mexico, a difference of 1.1%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Mexico ahead.
Gambia ranks 149th and Mexico ranks 152nd of 185 countries.
Across the 3 decades both report, Gambia averaged higher in 1 and Mexico in 2.
Head to head by decade
| Decade | Gambia | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 68.2% | 87.8% | 19.6% | Mexico |
| 2010s | 69.9% | 90.4% | 20.5% | Mexico |
| 2020s | 67.1% | 65.2% | 1.9% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Gambia or Mexico?
- Gambia, at 65.0% against 63.9% in Mexico as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Gambia and Mexico?
- 1.1%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Mexico?
- 6 years are reported by both, from 2000 to 2021.
- How do Gambia and Mexico rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Gambia ranks 149th and Mexico ranks 152nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.